Gene transfer in human vestibular epithelia and the prospects for inner ear gene therapy

Laryngoscope

Volumn 118, Issue 5, 2008, Pages 821-831

  Kesser, Bradley W ^a   Hashisaki, George T ^a   Holt, Jeffrey R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adenovirus; Gene transfer; Human; Transfection; Vestibular epithelia

Indexed keywords

ADENOVIRUS VECTOR; AMINOGLYCOSIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; DIURETIC AGENT; GELATIN SPONGE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LIPOSOME; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KCNQ4;

CELL REGENERATION; CELL SURVIVAL; EPITHELIUM CELL; GENE MUTATION; GENE TRANSFER; GENETIC TRANSFECTION; HAIR CELL; HERPES SIMPLEX VIRUS; HUMAN; LABYRINTHECTOMY; LENTIVIRINAE; MENIERE DISEASE; NEURILEMOMA; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; SPIRAL GANGLION; VACCINIA VIRUS; VESTIBULE;

BRAIN-DERIVED NEUROTROPHIC FACTOR; EAR DISEASES; EAR, INNER; EPITHELIUM; FEASIBILITY STUDIES; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HAIR CELLS, AUDITORY, INNER; HAIR CELLS, AUDITORY, OUTER; HEARING LOSS, SENSORINEURAL; HUMANS; KCNQ POTASSIUM CHANNELS; MENIERE DISEASE; NEUROMA, ACOUSTIC; REGENERATION; TISSUE AND ORGAN HARVESTING; TRANSFECTION; VESTIBULE, LABYRINTH;

EID: 43049097868     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e318164d0aa     Document Type: Review

References (96)

1. Lalwani AK, Castelein CM. Cracking the auditory genetic code: nonsyndromic hereditary hearing impairment. Am J Otol 1999;20:115-132.
2. Raphael Y, Frisancho JC, Roessler BJ. Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci Lett 1996;207:137-141.
3. Weiss MA, Frisancho JC, Roessler BJ, Raphael Y. Viral-mediated gene transfer in the cochlea. Int J Devel Neurosci 1997;15:577-583.
4. Dazert. Transfection of neonatal rat cochlear cells in vitro with an adenovirus vector. Int J Devel Neurosci 1997;15:595-600.
5. Lalwani AK, Walsh BJ, Reilly PG, Muzyczka N, Mhatre AN. Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Ther 1996;3:588-592.
6. Lalwani AK, Han JJ, Walsh BJ, Zolotukhin S, Muzyczka N, Mhatre AN. Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear Res 1997;114:139-147.
7. Staecker H, Li D, O'Malley BW, Van de Water TR. Gene expression in the mammalian cochlea: A study of multiple vector systems. Acta Otolaryngol 2001;121:157-163.
8. Derby ML, Sena-Esteves M, Breakefield XO, Corey DP. Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res 1999;134:1-8.
9. Han JJ, Mhatre AN, Wareing M, et al. Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector. Hum Gene Ther 1999;10:1867-1873.
10. Wareing M, Mhatre AN, Pettis R, et al. Cationic liposome mediated transgene expression in the guinea pig cochlea. Hear Res 1999;128:61-69.
11. Jero J, Mhatre AN, Tseng CJ, et al. Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther 2001;12:539-548.
12. Kawamoto K, Yagi M, Stover T, Kanzaki S, Raphael Y. Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol Ther 2003;7:484-492.
13. Kawamoto K, Sha SH, Minoda R, et al. Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther 2004;9:173-181.
14. Lalwani AK, Han JJ, Castelein CM, Carvalho GJ, Mhatre AN. In vitro and in vivo assessment of the ability of adeno-associated virus-brain-derived neurotrophic factor to enhance spiral ganglion cell survival following ototoxic insult. Laryngoscope 2002;112:1325-1334.
15. Staecker H, Gabaizadeh R, Federoff H, Van de Water TR. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 1998;119:7-13.
16. Yagi M, Kanzaki S, Kawamoto K, et al. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 2000;1:315-325.
17. Nakaizumi T, Kawamoto K, Minoda R, Raphael Y. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 2004;9:135-143.
18. Kawamoto K, Ishimoto S, Minoda R, Brough de, Raphael Y. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 2003;23:4395-4400.
19. Izumikawa M, Minoda R, Kawamoto K, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals [see comment]. Nat Med 2005;11:271-276.
20. Kesser BW, Hashisaki GT, Fletcher K, Eppard H, Holt JR. An in vitro model system to study gene therapy in the human inner ear. Gene Ther 2007;14:1121-1131.
21. Holt JR, Johns DC, Wang S, et al. Functional expression of exogenous proteins in mammalian sensory hair cells infected with adenoviral vectors. J Neurophysiol 1999;81:1881-1888.
22. Geschwind MD, Hartnick CJ, Liu W, Amat J, Van de Water TR, Federoff HJ. Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration. Hum Gene Ther 1996;7:173-182.
23. Di Pasquale G, Rzadzinska A, Schneider ME, Bossis I, Chiorini JA, Kachar B. A novel bovine virus efficiently transduces inner ear neuroepithelial cells. Mol Ther 2005;11:849-855.
24. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998;95:2509-2514.
25. Luebke AE, Foster PK, Muller CD, Peel AL. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Hum Gene Ther 2001;12:773-781.
26. Holt JR. Viral-mediated gene transfer to study the molecular physiology of the mammalian inner ear. Audiol Neurootol 2002;7:157-160.
27. Luebke AE, Steiger JD, Hodges BL, Amalfitano A. A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function. Gene Ther 2001;8:789-794.
28. Corey DP, Garcia-Anoveros J, Holt JR, et al. TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells [see comment]. Nature 2004;432:723-730.
29. Holt JR, Stauffer EA, Abraham D, Geleoc GS. Dominant-negative inhibition of M-like potassium conductances in hair cells of the mouse inner ear. J Neurosci 2007;27:8940-8951.
30. Amalfitano A. Utilization of adenovirus vectors for multiple gene transfer applications [Review, 95 refs]. Methods (Duluth) 2004;33:173-178.
31. Kawamoto K, Oh SH, Kanzaki S, Brown N, Raphael Y. The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice. Mol Ther 2001;4:575-585.
32. Ishimoto S, Kawamoto K, Kanzaki S, Raphael Y. Gene transfer into supporting cells of the organ of Corti. Hear Res 2002;173:187-197.
33. Yamasoba T, Suzuki M, Kondo K. Transgene expression in mature guinea pig cochlear cells in vitro. Neurosci Lett 2002;335:13-16.
34. Han D, Yu Z, Fan E, et al. Morphology of auditory hair cells in guinea pig cochlea after transgene expression. Hear Res 2004;190:25-30.
35. Smith AE. Viral vectors in gene therapy. Annu Rev Microbiol 1995;49:807-838.
36. Lalwani A, Walsh B, Reilly P, et al. Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Ther 1998;5:277-281.
37. Lalwani AK, Walsh BJ, Carvalho GJ, Muzyczka N, Mhatre AN. Expression of adeno-associated virus integrated transgene within the mammalian vestibular organs. Am J Otol 1998;19:390-395.
38. Stone IM, Lurie DI, Kelley MW, Poulsen DJ. Adeno-associated virus-mediated gene transfer to hair cells and support cells of the murine cochlea. Mol Ther 2005;11:843-848.
39. Kaplitt MG, Leone P, Samulski RJ, et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994;8:148-154.
40. Lalwani AK, Mhatre AN. Cochlear gene therapy [Review, 26 refs]. Ear Hear 2003;24:342-348.
41. Palu G, Parolin C, Takeuchi Y, Pizzato M. Progress with retroviral gene vectors. Rev Med Virol 2000;10:185-202.
42. Gunzburg WH, Salmons B. Development of retroviral vectors as safe, targeted gene delivery systems. J Mol Med 1996;74:171-182.
43. Ailles LE, Naldini L. HIV-1-derived lentiviral vectors. Curr Top Microbiol Immunol 2002;261:31-52.
44. Leventis R, Silvius JR. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles. Biochim Biophys Acta 1990;1023:124-132.
45. Jero J, Tseng CJ, Mhatre AN, Lalwani AK. A surgical approach appropriate for targeted cochlear gene therapy in the mouse. Hear Res 2001;151:106-114.
46. Stover T, Yagi M, Raphael Y. Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther 2000;7:377-383.
47. Stover T, Yagi M, Raphael Y. Cochlear gene transfer: round window versus cochleostomy inoculation. Hear Res 1999;136:124-130.
48. Dazert S, Aletsee C, Brors D, Gravel C, Sendtner M, Ryan A. In vivo adenoviral transduction of the neonatal rat cochlea and middle ear. Hear Res 2001;151:30-40.
49. Yamasoba T, Yagi M, Roessler BJ, Miller JM, Raphael Y. Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac. Hum Gene Ther 1999;10:769-774.
50. Praetorius M, Knipper M, Schick B, et al. A novel vestibular approach for gene transfer into the inner ear. Audiol Neurootol 2002;7:324-334.
51. Neyroud N, Tesson F, Denjoy I, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome [see comment]. Nat Genet 1997;15:186-189.
52. Schulze-Bahr E, Wang Q, Wedekind H, et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 1997;17:267-268.
53. Kubisch C, Schroeder BC, Friedrich T, et al. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 1999;96:437-446.
54. Kharkovets T, Hardelin JP, Safieddine S, et al. KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway [see comment]. Proc Natl Acad Sci USA 2000;97:4333-4338.
55. Kharkovets T, Dedek K, Maier H, et al. Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness. EMBO J 2006;25:642-652.
56. Ernfors P, Van de Water T, Loring J, Jaenisch R. Complementary roles of BDNF and NT-3 in vestibular and auditory development [erratum, Neuron 1995;15:739]. Neuron 1995;14:1153-1164.
57. Morrison RS, Kinoshita Y, Johnson MD, Ghatan S, Ho JT, Garden G. Neuronal survival and cell death signaling pathways. Adv Exp Med Biol 2002;513:41-86.
58. Staecker H, Kopke R, Malgrange B, Lefebvre P, Van de Water TR. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996;7:889-894.
59. Ylikoski J, Pirvola U, Virkkala J, et al. Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 1998;124:17-26.
60. Kuang R, Hever G, Zajic G, et al. Glial cell line-derived neurotrophic factor. Potential for otoprotection. Ann NY Acad Sci 1999;884:270-291.
61. Kanzaki S, Stover T, Kawamoto K, et al. Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol 2002;454:350-360.
62. Shoji F, Miller AL, Mitchell A, Yamasoba T, Altschuler RA, Miller JM. Differential protective effects of neurotrophins in the attenuation of noise-induced hair cell loss. Hear Res 2000;146:134-142.
63. Lopez I, Honrubia V, Lee S, et al. The protective effect of brain-derived neurotrophic factor after gentamicin ototoxicity. Am J Otol 1999;20:317-324.
64. Keithley EM, Ma CL, Ryan AF, Louis JC, Magal E. GDNF protects the cochlea against noise damage. Neuroreport 1998;9:2183-2187.
65. Shoji F, Yamasoba T, Magal E, Dolan DF, Altschuler RA, Miller JM. Glial cell line-derived neurotrophic factor has a dose dependent influence on noise-induced hearing loss in the guinea pig cochlea. Hear Res 2000;142:41-5.
66. Suzuki M, Yagi M, Brown JN, Miller AL, Miller JM, Raphael Y. Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity. Gene Ther 2000;7:1046-1054.
67. Yamasoba T, Schacht J, Shoji F, Miller JM. Attenuation of cochlear damage from noise trauma by an iron chelator, a free radical scavenger and glial cell line-derived neurotrophic factor in vivo. Brain Res 1999;815:317-325.
68. Ohinata Y, Yamasoba T, Schacht J, Miller JM. Glutathione limits noise-induced hearing loss. Hear Res 2000;146:28-34.
69. Pourbakht A, Yamasoba T. Ebselen attenuates cochlear damage caused by acoustic trauma. Hear Res 2003;181:100-10.
70. Yamasoba T, Pourbakht A, Sakamoto T, Suzuki M. Ebselen prevents noise-induced excitotoxicity and temporary threshold shift. Neurosci Lett 2005;380:234-238.
71. Fekete DM, Muthukumar S, Karagogeos D. Hair cells and supporting cells share a common progenitor in the avian inner ear. J Neurosci 1998;18:7811-7821.
72. Cotanche DA. Structural recovery from sound and aminoglycoside damage in the avian cochlea. Audiol Neurootol 1999;4:271-285.
73. Adler HJ, Raphael Y. New hair cells arise from supporting cell conversion in the acoustically damaged chick inner ear. [erratum, Neurosci Lett 1996;24;210:73.] Neurosci Lett 1996;205:17-20.
74. Bermingham NA, Hassan BA, Price SD, et al. Math1: an essential gene for the generation of inner ear hair cells. Science 1999;284:1837-1841.
75. Zheng JL, Gao WQ. Overexpression of Math1 induces robust production of extra hair cells in postnatal rat inner ears. Nat Neurosci 2000;3:580-586.
76. Shou J, Zheng JL, Gao WQ. Robust generation of new hair cells in the mature mammalian inner ear by adenoviral expression of Hath1. Mol Cell Neurosci 2003;23:169-179.
77. Staecker H, Praetorius M, Baker K, Brough DE. Vestibular hair cell regeneration and restoration of balance function induced by math1 gene transfer. Otol Neurotol 2007;28:223-231.
78. Sugahara K, Shimogori H, Okuda T, Takemoto T, Yamashita H. Novel method for homogeneous gene transfer to the inner ear. Acta Otolaryngol Suppl 2004:19-22.
79. Kanzaki S, Beyer L, Karolyi IJ, et al. Transgene correction maintains normal cochlear structure and function in 6-month-old Myo15a mutant mice. Hear Res 2006;214:37-40.
80. Staecker H, Brough DE, Praetorius M, Baker K. Drug delivery to the inner ear using gene therapy [Review, 64 refs]. Otolaryngol Clin North Am 2004;37:1091-1108.
81. Praetorius M, Baker K, Weich CM, Plinkert PK, Staecker H. Hearing preservation after inner ear gene therapy: the effect of vector and surgical approach. ORL J Otorhinolaryngol Relat Spec 2003;65:211-214.
82. Carvalho GJ, Lalwani AK. The effect of cochleostomy and intracochlear infusion on auditory brain stem response threshold in the guinea pig. Am J Otol 1999;20:87-90.
83. Kho ST, Pettis RM, Mhatre AN, Lalwani AK. Cochlear microinjection and its effects upon auditory function in the guinea pig. Eur Arch Otorhinolaryngol 2000;257:469-472.
84. Swiderski DL, Johnson M, Raphael Y. A new surgical approach for injections into the guinea pig cochlea [Abstract 283]. From the Abstracts of the Twenty-Ninth Annual Midwinter Research Meeting, Association for Research in Otolaryngology, 2006.
85. Self T, Mahony M, Fleming J, Walsh J, Brown SD, Steel KP. Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells. Development 1998;125:557-566.
86. Weil D, Blanchard S, Kaplan J, et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995;374:60-61.
87. Verpy E, Leibovici M, Zwaenepoel I, et al. A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C [see comment]. Nat Genet 2000;26:51-55.
88. Di Palma F, Holme RH, Bryda EC, et al. Mutations in Cdh23, encoding a new type of cadherin, cause stereocilia disorganization in waltzer, the mouse model for Usher syndrome type 1D. Nat Genet 2001;27:103-107.
89. Bork JM, Peters LM, Riazuddin S, et al. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet 2001;68:26-37.
90. Alagramam KN, Murcia CL, Kwon HY, Pawlowski KS, Wright CG, Woychik RP. The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene. Nat Genet 2001;27:99-102.
91. Ahmed ZM, Riazuddin S, Ahmad J, et al. PCDH15 is expressed in the neurosensory epithelium of the eye and ear and mutant alleles are responsible for both USH1F and DFNB23. Hum Mol Genet 2003;12:3215-3223.
92. Weil D, El-Amraoui A, Masmoudi S, et al. Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin. Hum Mol Genet 2003;12:463-471.
93. Ahmed ZM, Morell RJ, Riazuddin S, et al. Mutations of MYO6 are associated with recessive deafness, DFNB37. Am J Hum Genet 2003;72:1315-1322.
94. Melchionda S, Ahituv N, Bisceglia L, et al. MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet 2001;69:635-640.
95. Probst FJ, Fridell RA, Raphael Y, et al. Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene [see comment]. Science 1998;280:1444-1447.
96. Wang A, Liang Y, Fridell RA, et al. Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3 [see comment]. Science 1998;280:1447-1451.